PURPOSE: This study compared the WHO criteria with the response evaluation criteria in solid tumors (RECIST) in the same patients with metastatic colorectal cancer in order to determine the significance of the RECIST. In addition, this study compared the estimations of medical oncologists with those of a radiologist. MATERIALS AND METHODS: Between 2002 and 2005, a total of 48 patients (male: female ratio, 29:19; median age, 58 years) with measurable lesions receiving chemotherapy for metastatic colorectal carcinoma were enrolled in this study. Two medical oncologists and one radiologist, who were blinded to the patients' condition, independently reviewed all the CT images. The results were compared using a kappa test. RESULTS: The kappa test for concordance between the WHO and RECIST criteria of the medical oncologists and the radiologist were 0.908 and 0.841, respectively. The level of concordance between the investigators using the WHO and RECIST were 0.722 and 0.753, respectively. CONCLUSION: The RECIST criteria are comparable to the WHO criteria in evaluating the response of colorectal carcinoma, but have simple and reproducible guidelines. The use of RECIST is recommended for evaluating the treatment efficacy in clinical trials and practice.
PURPOSE: This study compared the WHO criteria with the response evaluation criteria in solid tumors (RECIST) in the same patients with metastatic colorectal cancer in order to determine the significance of the RECIST. In addition, this study compared the estimations of medical oncologists with those of a radiologist. MATERIALS AND METHODS: Between 2002 and 2005, a total of 48 patients (male: female ratio, 29:19; median age, 58 years) with measurable lesions receiving chemotherapy for metastatic colorectal carcinoma were enrolled in this study. Two medical oncologists and one radiologist, who were blinded to the patients' condition, independently reviewed all the CT images. The results were compared using a kappa test. RESULTS: The kappa test for concordance between the WHO and RECIST criteria of the medical oncologists and the radiologist were 0.908 and 0.841, respectively. The level of concordance between the investigators using the WHO and RECIST were 0.722 and 0.753, respectively. CONCLUSION: The RECIST criteria are comparable to the WHO criteria in evaluating the response of colorectal carcinoma, but have simple and reproducible guidelines. The use of RECIST is recommended for evaluating the treatment efficacy in clinical trials and practice.
Entities:
Keywords:
Metastatic colorectal carcinoma; RECIST; Tumor response; WHO
Authors: V Trillet-Lenoir; G Freyer; P Kaemmerlen; A Fond; O Pellet; C Lombard-Bohas; J L Gaudin; G Lledo; R Mackiewicz; M C Gouttebel; H Moindrot; J D Boyer; L Chassignol; N Stremsdoerfer; F Desseigne; J M Moreau; F Hedelius; A Moraillon; F Chapuis; J P Bleuse; Y Barbier; M O Heilmann; P J Valette Journal: Br J Radiol Date: 2002-11 Impact factor: 3.039
Authors: P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther Journal: J Natl Cancer Inst Date: 2000-02-02 Impact factor: 13.506
Authors: P Thiesse; L Ollivier; D Di Stefano-Louineau; S Négrier; J Savary; K Pignard; C Lasset; B Escudier Journal: J Clin Oncol Date: 1997-12 Impact factor: 44.544
Authors: K James; E Eisenhauer; M Christian; M Terenziani; D Vena; A Muldal; P Therasse Journal: J Natl Cancer Inst Date: 1999-03-17 Impact factor: 13.506
Authors: Jeremy J Erasmus; Gregory W Gladish; Lyle Broemeling; Bradley S Sabloff; Mylene T Truong; Roy S Herbst; Reginald F Munden Journal: J Clin Oncol Date: 2003-07-01 Impact factor: 44.544
Authors: Srinivasa R Prasad; Sanjay Saini; James E Sumner; Peter F Hahn; Dushyant Sahani; Giles W Boland Journal: J Comput Assist Tomogr Date: 2003 May-Jun Impact factor: 1.826
Authors: Joon Oh Park; Soon Il Lee; Seo Young Song; Kihyun Kim; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuk Im; Won Ki Kang; Mark Hong Lee; Kyung Soo Lee; Keunchil Park Journal: Jpn J Clin Oncol Date: 2003-10 Impact factor: 3.019
Authors: Clemens Hufnagl; Michael Leisch; Lukas Weiss; Thomas Melchardt; Martin Moik; Daniela Asslaber; Geisberger Roland; Philipp Steininger; Thomas Meissnitzer; Daniel Neureiter; Richard Greil; Alexander Egle Journal: Oncol Lett Date: 2019-12-09 Impact factor: 2.967
Authors: Hyun Chang Choi; Jung Han Kim; Hyeong Su Kim; Soong Goo Jung; Sang Muk Hwang; Sung Bae Ju; Ik Yang Journal: J Cancer Date: 2015-05-27 Impact factor: 4.207